Dr. Atul D Abhyankar
MD, DM, FACC, FSCAI, FAPSIC, FCSI, FISE Interventional Cardiologist
- Phone-No: 98241-45738
- Phone-No: 90992-31122
- Email: atulda@hotmail.com
multicenter National and global trials
Trial Related Molecules
& Devices
- Rivaroxaban
- Rivaroxaban low Dose
- Sacubitril Valsartan
- Vaespladib
- Sitaxentan
- Canacunimab
- Ticagrelor
- Prasugrel
- Pemafibrate
- Bempedoic Acid
- Semaglutide
- Alirocumab
- Alogliptin
- Thyroxin Analogue
- Long acting nitrate
- Otamixaban
- Amlodipine
- Irbesartan
- Ultimaster Stent
- Tetriflex/Tetrilimus Stent
- Pronova Stent
- Nostrum Stent
Clinical Condition
- Non Valvular AF
- Heart Failure
- Unstable Angina
- Acute Coronary Syndrome
- ACS undergoing PCI
- ACS post PCI
- Hypercholesterolemia
- Stable CAD
- Primary Pulmonary Hypertension
- Statin Intolerance
- Familial Hypercholesterolemia
- CAD with high BMI
- CAD with Diabetes
- PCI with High Bleeding Risk
- PCI in Diabetics
- PCI in AMI
- Multivessel PCI
- Hypertension
Sponsors
- Bayer
- Sanofi
- Pfizer
- Astra Zeneca
- Novartis
- Johnson & Johnson
- Kova
- Anthera
- Novo Nordisk
- Espirion
- Torrent
- Actavis
- Terumo
- Boston Scientific
- Abbott
- Sahajanand Medical
- Technologies
- Vascular Concepts
- Envision Scientific
Research Organizations
- Quintiles
- Iqova
- ECCRI
- Kendle
- Novo Nordisk
- Paraxel
- Batra Hospital &
- Research Centre
- Max Neeman
- JSS
- SIRO
- Tech Observer
- Pacific
- Trident
- WCT